期刊文献+

介入治疗对急性心肌梗死心肌灌注呈色影响的研究进展 被引量:5

Research advances of the effects of interventional therapy on myocardial blush grade of acute myocardial infarction
下载PDF
导出
摘要 目前,经皮冠状动脉介入(percutaneous coronary intervention,PCI)治疗已成为急性心肌梗死(acute myocardial infarction,AMI)最主要的血管开通手段.然而梗死相关动脉开通后心肌灌注程度才是心肌存活的最主要因素,因此准确评价心肌灌注状况对患者预后有重要意义.当前,临床用于评价心肌灌注状况的方法较多,例如TIMI血流分级法、心肌灌注呈色(myocardial blush grade,MBG)分级法、正电子放射断层扫描(PET)、心肌声学造影(MCE)和99mTc-MIBI心肌灌注断层显像(SPECT)等方法.其中MBG分级法具有客观、简单、经济、重复性好等特性,已广泛用于临床,尤其随着介入技术的发展如支架置入技术、血栓抽吸技术及冠状动脉内注入血小板GP IIb/IIIa受体拮抗剂等,这些技术都提高了心肌灌注MBG程度,现就近几年来这方面的研究进展做一综述. At present, percutaneous coronary intervention (PCI) therapy has been a main recanalizition way for the infarct -related artery in the patients with acute myocardial infarction. However, the major factor of survivable myocardium depends on the reperfusion grades after the infarct - related artery opening. Thus, a accurately appraisal way used to evaluate myocardial reperfusion grades is significant for the patients in the prognosis. Nowadays, there are many methods we can take, such as thrombolysis in myocardial infarction ( TIMI ), myocardial blush grade ( MBG ), single - photon emission computed temography (SPECT), positive emission tomography (PET), myocardial contrast echocardiography (MCE). Among them, the MBG has been widely used in clinical practice because of its actual, simple, economic, reusable features. Especially, the development of interventional therapy, such as stent implanting, thrombus aspiration and GP Ⅱb/Ⅲa receptor inhibitor used in coronary, greatly improves the MBG. We will sum up the advances about it in recent years.
出处 《中国急救医学》 CAS CSCD 北大核心 2011年第11期1029-1032,共4页 Chinese Journal of Critical Care Medicine
关键词 急性心肌梗死 替罗非班 经皮冠状动脉血管成形术 血栓抽吸 Acute myocardial infarction Tirofiban Percutaneous coronary intervention Thrombus aspiration
  • 相关文献

参考文献2

二级参考文献1

共引文献67

同被引文献39

  • 1中华医学会心血管病学分会.急性心肌梗死诊断和治疗指南.中华心血管病杂志,2010,29(12):713-714.
  • 2Enrico V, Ivano B, Gregoriana Z, et al. Homocysteine and heart failure: an overview [ J] . Recent Pat Cardio- vasc Drug Discov, 2009, 4 (1) : 15-21.
  • 3Boushey C J, Beresford SA, Omenn GS, et al. A quanti- tative assessment of plasma homocysteine as a risk factor for vascular disease, probable benefits of increasing folic acid intakes [J] . JAMA, 1995, 274 (13): 1049- 1057.
  • 4Cesari M, Rossi GP, Pessina AC. Homocysteine-lowering treatment in coronary heart disease [ J ] . Curr Med Chem Cardiovasc Hematol Agents, 2005, 3 (4) : 289- 295.
  • 5Nasir KN, Tsai M, Rosen B, et al. Elevated homocys- teine is associated with reduced regional left ventricular function: the multi-Ethnic study of atherosclerosis [ J ] . Circulation, 2007, 115 (2): 180-187.
  • 6Zhu WG, Li S, Lin LQ, et al. Vascular oxidative stress increases dendritic cell adhesion and transmigration in- duced by homocysteine [ J] . Cell Immunol, 2009, 254 (2) : 110-116.
  • 7Ebbing M, Bleie 0, Ueland PM, et al. Mortality and cardiovascular events in patients treated with homocys- teine-lowering B vitamins after coronary angiography: a randomized controlled trial [ J ] . JAMA, 2008, 300 (7) : 795-804.
  • 8卢志红,王盂杰,邱小芩,等.高危急性心梗患者介入治疗主动脉球囊反搏应用时机选择[J].医药前沿,2015,(29):32-33.
  • 9陈小亮,刘向儒,唐春仕,等.冠脉内逆向注射尿激酶与替罗非班对预防急性心梗患者介入治疗中无复流的对比研究[J].医药前沿,2014,(33):393-394.
  • 10陈琦玲,王鸿懿,孙宁玲.血浆同型半胱氨酸与冠心病及高血压的相关性研究[J].中华老年心脑血管病杂志,2010,12(3):233-235. 被引量:31

引证文献5

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部